17 July 2024 : Clinical Research
Prognostic Impact of Tumor-Infiltrating Immune Cells on Efficacy of Neoadjuvant Chemotherapy in Patients with Advanced or Metastatic Ovarian Cancer: A Retrospective Study
Qunxian Rao1BCE, Miaoling Huang1B, Meimei Guan1C, Changhao Liu1D, Lijuan Wang1D, Zhongqiu Lin1A*, Qing Chen1ADOI: 10.12659/MSM.943170
Med Sci Monit 2024; 30:e943170
Supplementary Table 1 The clinicopathological characteristics of each patient.
| Patient number | Neoadjuvant effect | Age | Family history of cancer | Other cancer history | Histological | Stages | PFS (months) | PFS.status |
|---|---|---|---|---|---|---|---|---|
| p1 | No benefit | 57 | Y | Y | Low grade | IIIC | 12,633333 | 1 |
| p2 | Benefit | 55 | Y | Y | High grade | IIIC | 4,4666667 | 0 |
| p3 | Benefit | 64 | N | Y | High grade | IV | 5,6666667 | 0 |
| p4 | Benefit | 60 | N | N | High grade | IV | 21,033333 | 1 |
| p5 | Benefit | 63 | N | N | High grade | IIIC | 4,8333333 | 0 |
| p10 | Benefit | 64 | N | N | High grade | IIIC | 18,366667 | 1 |
| p11 | Benefit | 62 | N | Y | High grade | IV | 6,3666667 | 0 |
| p14 | Benefit | 54 | N | Y | High grade | IIIC | 5,2666667 | 0 |
| p15 | Benefit | 71 | Y | Y | High grade | IIIC | 10,033333 | 1 |
| p17 | Benefit | 65 | N | N | High grade | IIIC | 4,7666667 | 0 |
| p18 | Benefit | 50 | N | Y | High grade | IIIC | 10,4 | 1 |
| p21 | Benefit | 52 | Y | N | High grade | IIIC | 4,1 | 0 |
| p24 | Benefit | 57 | N | N | High grade | IIIC | 5,7333333 | 0 |
| p25 | Part benefit | 57 | N | N | High grade | IIIC | 19,2 | 0 |
| p26 | Benefit | 64 | N | N | High grade | IIIC | 14,533333 | 1 |
| p27 | Benefit | 57 | N | N | High grade | IIIC | 13,3 | 0 |
| p28 | Benefit | 43 | N | Y | High grade | IV | 4,5666667 | 0 |
| p31 | Benefit | 47 | N | N | High grade | IIIC | 4,0333333 | 0 |
| p32 | Part benefit | 48 | N | N | High grade | IIIC | 4,7333333 | 0 |
| p33 | Benefit | 42 | N | N | High grade | IV | 10,666667 | 0 |
| p34 | Benefit | 52 | N | N | High grade | IIIB | 25,933333 | 1 |
| p35 | Benefit | 65 | N | N | High grade | IV | 27,433333 | 1 |
| p36 | Part benefit | 61 | N | N | High grade | IIIC | 22,833333 | 1 |
| p37 | Benefit | 50 | N | N | High grade | IIIC | 4 | 0 |
| p38 | Part benefit | 46 | Y | N | High grade | IIIC | 4,7 | 0 |
| p39 | Part benefit | 56 | N | N | High grade | IIIB | 14,5 | 1 |
| p40 | Part benefit | 66 | N | N | High grade | IV | 17,7 | 1 |
| p41 | Benefit | 61 | N | N | High grade | IIIC | 8,8333333 | 1 |
| p42 | Benefit | 67 | N | N | High grade | IIIC | 37,5 | 1 |
| p43 | Benefit | 72 | N | N | High grade | IV | 4,0333333 | 0 |
| p44 | Benefit | 63 | N | Y | High grade | IIIC | 4,1 | 0 |






